About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
Congress passed the Bayh-Dole Act in 1980 with strong bipartisan support, creating a framework where researchers receiving federal funds could patent their inventions and license them to private companies so they could continue to research and develop them into products that benefit the public. This landmark legislation ensures that innovative ideas are protected and brought to market. It has contributed nearly $2 trillion to the U.S. economy and supported 6.5 million jobs.
Bayh-Doyle preview
Fact Sheet
The Bayh-Dole Act: Spurring American Biopharmaceutical Innovation
Bayh-Doyle preview